Marsh, Glenn A. http://orcid.org/0000-0002-3469-1837
McAuley, Alexander J. http://orcid.org/0000-0002-7632-9633
Au, Gough G. http://orcid.org/0000-0001-6923-8875
Riddell, Sarah
Layton, Daniel
Singanallur, Nagendrakumar B.
Layton, Rachel
Payne, Jean
Durr, Peter A. http://orcid.org/0000-0003-0851-5300
Bender, Hannah
Barr, Jennifer A. http://orcid.org/0000-0001-5266-9142
Bingham, John
Boyd, Victoria
Brown, Sheree
Bruce, Matthew P.
Burkett, Kathie
Eastwood, Teresa
Edwards, Sarah
Gough, Tamara http://orcid.org/0000-0002-0878-954X
Halpin, Kim
Harper, Jenni
Holmes, Clare
Horman, William S. J.
van Vuren, Petrus Jansen http://orcid.org/0000-0003-2862-7983
Lowther, Suzanne
Maynard, Kate
McAuley, Kristen D.
Neave, Matthew J.
Poole, Timothy
Rootes, Christina http://orcid.org/0000-0002-7448-8307
Rowe, Brenton
Soldani, Elisha
Stevens, Vittoria
Stewart, Cameron R.
Suen, Willy W.
Tachedjian, Mary
Todd, Shawn
Trinidad, Lee
Walter, Duane
Watson, Naomi
Drew, Trevor W. http://orcid.org/0000-0002-0448-1062
Gilbert, Sarah C. http://orcid.org/0000-0002-6823-9750
Lambe, Teresa http://orcid.org/0000-0001-7711-897X
Vasan, S. S. http://orcid.org/0000-0002-7326-3210
Funding for this research was provided by:
Coalition for Epidemic Preparedness Innovations
Article History
Received: 12 January 2021
Accepted: 12 March 2021
First Online: 10 May 2021
Competing interests
: Oxford University has entered into a partnership with AstraZeneca for further development of ChAdOx1 nCoV-19. S.C.G. is a co-founder of Vaccitech (collaborators in the early development of this vaccine candidate) and named as an inventor on a patent covering the use of ChAdOx1-vectored vaccines and a patent application covering this SARS-CoV-2 vaccine (PCT/GB2012/000467). T.L. is named as an inventor on a patent application covering this SARS-CoV-2 vaccine and was a consultant to Vaccitech for an unrelated project, during the conduct of the study. The remaining authors declare no competing interests.